Literature DB >> 9950748

In vitro models of T cell development.

K J Hare1, E J Jenkinson, G Anderson.   

Abstract

A number of in vitro systems are currently being used to study both thymocyte development and thymic stromal cell function. However, the usefulness of dispersed culture systems is limited since they often involve disruption of interactions within the normal three-dimensional architecture of the thymus in vivo which are critical for normal development to proceed. In contrast, Fetal Thymus Organ Culture (FTOC) provides an experimental system where such interactions are maintained, thereby allowing in vitro access to key aspects of thymocyte development. More recently, Reaggregate Thymus Organ Cultures (RTOCs) have allowed detailed analysis of thymic stromal cell function, while retroviral transfection of thymocyte subsets under FTOC conditions provides a rapid means to investigate thymocyte development at the molecular level. Current use of the FTOC approach is summarised here, and where appropriate is compared to the use of dispersed culture systems. Copyright 1999 Academic Press.

Mesh:

Year:  1999        PMID: 9950748     DOI: 10.1006/smim.1998.0151

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  15 in total

Review 1.  Review article: thymus organ cultures and T-cell receptor repertoire development.

Authors:  G Anderson; E J Jenkinson
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

Review 2.  Reversing T cell immunosenescence: why, who, and how.

Authors:  Pierre Olivier Lang; Sheila Govind; Richard Aspinall
Journal:  Age (Dordr)       Date:  2012-02-26

Review 3.  The potential of non-myeloablative heterochronous autologous hematopoietic stem cell transplantation for extending a healthy life span.

Authors:  Primož Rožman
Journal:  Geroscience       Date:  2018-06-14       Impact factor: 7.713

4.  Preparation and Applications of Organotypic Thymic Slice Cultures.

Authors:  Aditi Sood; Mengqi Dong; Heather J Melichar
Journal:  J Vis Exp       Date:  2016-08-06       Impact factor: 1.355

Review 5.  Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells.

Authors:  Ann Peters; Paul W Burridge; Marina V Pryzhkova; Michal A Levine; Tea-Soon Park; Christopher Roxbury; Xuan Yuan; Bruno Péault; Elias T Zambidis
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

6.  Further differentiation of murine double-positive thymocytes is inhibited in adenosine deaminase-deficient murine fetal thymic organ culture.

Authors:  C Justin Van De Wiele; Michelle L Joachims; Amy M Fesler; James G Vaughn; Michael R Blackburn; Stephanie T McGee; Linda F Thompson
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

7.  Egr2 is required for Bcl-2 induction during positive selection.

Authors:  Jens-Peter Holst Lauritsen; Sridevi Kurella; Sang-Yun Lee; Juliette M Lefebvre; Michele Rhodes; José Alberola-Ila; David L Wiest
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

Review 8.  Adoptive precursor cell therapy to enhance immune reconstitution after hematopoietic stem cell transplantation in mouse and man.

Authors:  Amanda M Holland; Johannes L Zakrzewski; Gabrielle L Goldberg; Arnab Ghosh; Marcel R M van den Brink
Journal:  Semin Immunopathol       Date:  2008-11-15       Impact factor: 9.623

9.  Multiscale engineering of immune cells and lymphoid organs.

Authors:  Sungwoong Kim; Shivem B Shah; Pamela L Graney; Ankur Singh
Journal:  Nat Rev Mater       Date:  2019-04-03       Impact factor: 66.308

10.  Low ligand requirement for deletion and lack of synapses in positive selection enforce the gauntlet of thymic T cell maturation.

Authors:  Peter J R Ebert; Lauren I Richie Ehrlich; Mark M Davis
Journal:  Immunity       Date:  2008-11-14       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.